{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T02:17:51Z","timestamp":1719454671935},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T00:00:00Z","timestamp":1455148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Universit\u00e0 degli Studi di Milano (IT)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s12035-016-9775-8","type":"journal-article","created":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T06:43:20Z","timestamp":1455173000000},"page":"1564-1567","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Serum Antibodies to Glycans in Peripheral Neuropathies"],"prefix":"10.1007","volume":"54","author":[{"given":"Sandro","family":"Sonnino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Chiricozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Ciampa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Mauri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Prinetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gino","family":"Toffano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Aureli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,11]]},"reference":[{"key":"9775_CR1","first-page":"199","volume-title":"New comprehensive biochemistry","author":"H Wiegandt","year":"1985","unstructured":"Wiegandt H (1985) Chapter 3 gangliosides. In: Neuberger A, van Deenen LLM (eds) New comprehensive biochemistry. Elsevier, UK, pp 199\u2013260"},{"key":"9775_CR2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.patbio.2011.11.010","volume":"60","author":"J Labat-Robert","year":"2012","unstructured":"Labat-Robert J, Robert L (2012) Fifty years of structural glycoproteins. Pathol Biol (Paris) 60:66\u201375","journal-title":"Pathol Biol (Paris)"},{"key":"9775_CR3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.bi.60.070191.002303","volume":"60","author":"L Kjellen","year":"1991","unstructured":"Kjellen L, Lindahl U (1991) Proteoglycans: structures and interactions. Annu Rev Biochem 60:443\u2013475","journal-title":"Annu Rev Biochem"},{"key":"9775_CR4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/jnc.12088","volume":"124","author":"S Sonnino","year":"2013","unstructured":"Sonnino S, Mauri L, Ciampa MG, Prinetti A (2013) Gangliosides as regulators of cell signaling: ganglioside-protein interactions or ganglioside-driven membrane organization? J Neurochem 124:432\u2013435","journal-title":"J Neurochem"},{"key":"9775_CR5","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1093\/glycob\/cwl052","volume":"17","author":"S Sonnino","year":"2007","unstructured":"Sonnino S, Mauri L, Chigorno V, Prinetti A (2007) Gangliosides as components of lipid membrane domains. Glycobiology 17:1R\u201313R","journal-title":"Glycobiology"},{"key":"9775_CR6","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.febslet.2011.03.030","volume":"585","author":"HJ Maccioni","year":"2011","unstructured":"Maccioni HJ, Quiroga R, Spessott W (2011) Organization of the synthesis of glycolipid oligosaccharides in the Golgi complex. FEBS Lett 585:1691\u20131698","journal-title":"FEBS Lett"},{"key":"9775_CR7","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.bbamcr.2013.04.001","volume":"1833","author":"M Aebi","year":"2013","unstructured":"Aebi M (2013) N-linked protein glycosylation in the ER. Biochim Biophys Acta 1833:2430\u20132437","journal-title":"Biochim Biophys Acta"},{"key":"9775_CR8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0009-3084(94)02304-2","volume":"71","author":"S Sonnino","year":"1994","unstructured":"Sonnino S, Cantu L, Corti M, Acquotti D, Venerando B (1994) Aggregative properties of gangliosides in solution. Chem Phys Lipids 71:21\u201345","journal-title":"Chem Phys Lipids"},{"key":"9775_CR9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0264-410X(99)00219-4","volume":"18","author":"F Estevez","year":"1999","unstructured":"Estevez F, Carr A, Solorzano L, Valiente O, Mesa C, Barroso O, Sierra GV, Fernandez LE (1999) Enhancement of the immune response to poorly immunogenic gangliosides after incorporation into very small size proteoliposomes (VSSP). Vaccine 18:190\u2013197","journal-title":"Vaccine"},{"key":"9775_CR10","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-1-4419-7877-6_17","volume":"705","author":"RK Yu","year":"2011","unstructured":"Yu RK, Ariga T, Usuki S, Kaida K (2011) Pathological roles of ganglioside mimicry in Guillain-Barre syndrome and related neuropathies. Adv Exp Med Biol 705:349\u2013365","journal-title":"Adv Exp Med Biol"},{"key":"9775_CR11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2174\/187152706777950765","volume":"5","author":"T Komagamine","year":"2006","unstructured":"Komagamine T, Yuki N (2006) Ganglioside mimicry as a cause of Guillain-Barre syndrome. CNS Neurol Disord Drug Targets 5:391\u2013400","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"9775_CR12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.it.2013.05.001","volume":"34","author":"HJ Willison","year":"2013","unstructured":"Willison HJ, Goodyear CS (2013) Glycolipid antigens and autoantibodies in autoimmune neuropathies. Trends Immunol 34:453\u2013459","journal-title":"Trends Immunol"},{"key":"9775_CR13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/WCO.0b013e328364caca","volume":"26","author":"R Guimaraes-Costa","year":"2013","unstructured":"Guimaraes-Costa R, Bombelli F, Leger JM (2013) Multifocal motor neuropathy. Curr Opin Neurol 26:503\u2013509","journal-title":"Curr Opin Neurol"},{"key":"9775_CR14","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1023\/A:1020284302718","volume":"27","author":"GM O'Hanlon","year":"2002","unstructured":"O'Hanlon GM, Bullens RW, Plomp JJ, Willison HJ (2002) Complex gangliosides as autoantibody targets at the neuromuscular junction in Miller Fisher syndrome: a current perspective. Neurochem Res 27:697\u2013709","journal-title":"Neurochem Res"},{"key":"9775_CR15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bbadis.2014.06.013","volume":"1852","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC (2015) Pathogenesis of immune-mediated neuropathies. Biochim Biophys Acta 1852:658\u2013666","journal-title":"Biochim Biophys Acta"},{"key":"9775_CR16","first-page":"CD002827","volume":"5","author":"MP Lunn","year":"2012","unstructured":"Lunn MP, Nobile-Orazio E (2012) Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies. Cochrane Database Syst Rev 5:CD002827","journal-title":"Cochrane Database Syst Rev"},{"key":"9775_CR17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ncl.2006.10.002","volume":"25","author":"S Vernino","year":"2007","unstructured":"Vernino S, Wolfe GI (2007) Antibody testing in peripheral neuropathies. Neurol Clin 25:29\u201346","journal-title":"Neurol Clin"},{"key":"9775_CR18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ana.410280215","volume":"28","author":"E Nobile-Orazio","year":"1990","unstructured":"Nobile-Orazio E, Legname G, Daverio R, Carpo M, Giuliani A, Sonnino S, Scarlato G (1990) Motor neuron disease in a patient with a monoclonal IgMk directed against GM1, GD1b, and high-molecular-weight neural-specific glycoproteins. Ann Neurol 28:190\u2013194","journal-title":"Ann Neurol"},{"key":"9775_CR19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0165-5728(89)90036-2","volume":"23","author":"FP Thomas","year":"1989","unstructured":"Thomas FP, Lee AM, Romas SN, Latov N (1989) Monoclonal IgMs with anti-Gal(beta 1\u20133) GalNAc activity in lower motor neuron disease; identification of glycoprotein antigens in neural tissue and cross-reactivity with serum immunoglobulins. J Neuroimmunol 23:167\u2013174","journal-title":"J Neuroimmunol"},{"key":"9775_CR20","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jocn.2013.07.041","volume":"21","author":"W Johannis","year":"2014","unstructured":"Johannis W, Renno JH, Klatt AR, Wielckens K (2014) Anti-glycolipid antibodies in patients with neuropathy: a diagnostic assessment. J Clin Neurosci 21:488\u2013492","journal-title":"J Clin Neurosci"},{"key":"9775_CR21","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.7754\/Clin.Lab.2013.121116","volume":"59","author":"C Caudie","year":"2013","unstructured":"Caudie C, Quittard Pinon A, Bouhour F, Vial C, Garnier L, Fabien N (2013) Comparison of commercial tests for detecting multiple anti-ganglioside autoantibodies in patients with well-characterized immune-mediated peripheral neuropathies. Clin Lab 59:1277\u20131287","journal-title":"Clin Lab"},{"key":"9775_CR22","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.expneurol.2011.11.039","volume":"233","author":"K Susuki","year":"2012","unstructured":"Susuki K, Yuki N, Schafer DP, Hirata K, Zhang G, Funakoshi K, Rasband MN (2012) Dysfunction of nodes of Ranvier: a mechanism for anti-ganglioside antibody-mediated neuropathies. Exp Neurol 233:534\u2013542","journal-title":"Exp Neurol"},{"key":"9775_CR23","doi-asserted-by":"crossref","first-page":"6770","DOI":"10.1523\/JNEUROSCI.4926-14.2015","volume":"35","author":"L He","year":"2015","unstructured":"He L, Zhang G, Liu W, Gao T, Sheikh KA (2015) Anti-ganglioside antibodies induce nodal and axonal injury via Fcgamma receptor-mediated inflammation. J Neurosci 35:6770\u20136785","journal-title":"J Neurosci"},{"key":"9775_CR24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jnnp.2010.205856","volume":"82","author":"N Yuki","year":"2011","unstructured":"Yuki N, Watanabe H, Nakajima T, Spath PJ (2011) IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy. J Neurol Neurosurg Psychiatry 82:87\u201391","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"9775_CR25","doi-asserted-by":"crossref","first-page":"11658","DOI":"10.1074\/jbc.275.16.11658","volume":"275","author":"A Prinetti","year":"2000","unstructured":"Prinetti A, Chigorno V, Tettamanti G, Sonnino S (2000) Sphingolipid-enriched membrane domains from rat cerebellar granule cells differentiated in culture. A compositional study. J Biol Chem 275:11658\u201311665","journal-title":"J Biol Chem"},{"key":"9775_CR26","first-page":"4997","volume":"43","author":"R Kannagi","year":"1983","unstructured":"Kannagi R, Stroup R, Cochran NA, Urdal DL, Young WW Jr, Hakomori S (1983) Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells. Cancer Res 43:4997\u20135005","journal-title":"Cancer Res"},{"key":"9775_CR27","first-page":"4948","volume":"52","author":"KO Lloyd","year":"1992","unstructured":"Lloyd KO, Gordon CM, Thampoe IJ, DiBenedetto C (1992) Cell surface accessibility of individual gangliosides in malignant melanoma cells to antibodies is influenced by the total ganglioside composition of the cells. Cancer Res 52:4948\u20134953","journal-title":"Cancer Res"},{"key":"9775_CR28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/excr.1997.3563","volume":"233","author":"K Tatewaki","year":"1997","unstructured":"Tatewaki K, Yamaki T, Maeda Y, Tobioka H, Piao H, Yu H, Ibayashi Y, Sawada N et al (1997) Cell density regulates crypticity of GM3 ganglioside on human glioma cells. Exp Cell Res 233:145\u2013154","journal-title":"Exp Cell Res"},{"key":"9775_CR29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4049\/jimmunol.113.1.84","volume":"113","author":"M Naiki","year":"1974","unstructured":"Naiki M, Marcus DM, Ledeen R (1974) Properties of antisera to ganglioside GM1 and asialo GM1. J Immunol 113:84\u201393","journal-title":"J Immunol"},{"key":"9775_CR30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0079-6123(08)61941-X","volume":"101","author":"G Tettamanti","year":"1994","unstructured":"Tettamanti G, Riboni L (1994) Gangliosides turnover and neural cells function: a new perspective. Prog Brain Res 101:77\u2013100","journal-title":"Prog Brain Res"},{"key":"9775_CR31","doi-asserted-by":"crossref","first-page":"21136","DOI":"10.1074\/jbc.M010666200","volume":"276","author":"A Prinetti","year":"2001","unstructured":"Prinetti A, Chigorno V, Prioni S, Loberto N, Marano N, Tettamanti G, Sonnino S (2001) Changes in the lipid turnover, composition, and organization, as sphingolipid-enriched membrane domains, in rat cerebellar granule cells developing in vitro. J Biol Chem 276:21136\u201321145","journal-title":"J Biol Chem"},{"key":"9775_CR32","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1523\/JNEUROSCI.4279-04.2005","volume":"25","author":"JA Goodfellow","year":"2005","unstructured":"Goodfellow JA, Bowes T, Sheikh K, Odaka M, Halstead SK, Humphreys PD, Wagner ER, Yuki N et al (2005) Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. J Neurosci 25:1620\u20131628","journal-title":"J Neurosci"},{"key":"9775_CR33","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/brain\/awq119","volume":"133","author":"R McGonigal","year":"2010","unstructured":"McGonigal R, Rowan EG, Greenshields KN, Halstead SK, Humphreys PD, Rother RP, Furukawa K, Willison HJ (2010) Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. Brain 133:1944\u20131960","journal-title":"Brain"},{"key":"9775_CR34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1523\/JNEUROSCI.4017-06.2007","volume":"27","author":"HC Lehmann","year":"2007","unstructured":"Lehmann HC, Lopez PH, Zhang G, Ngyuen T, Zhang J, Kieseier BC, Mori S, Sheikh KA (2007) Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model. J Neurosci 27:27\u201334","journal-title":"J Neurosci"},{"key":"9775_CR35","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/infdis\/124.4.415","volume":"124","author":"WE Heyningen Van","year":"1971","unstructured":"Van Heyningen WE, Carpenter CC, Pierce NF, Greenough WB 3rd (1971) Deactivation of cholera toxin by ganglioside. J Infect Dis 124:415\u2013418","journal-title":"J Infect Dis"},{"key":"9775_CR36","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1021\/bi00123a030","volume":"31","author":"M Masserini","year":"1992","unstructured":"Masserini M, Freire E, Palestini P, Calappi E, Tettamanti G (1992) Fuc-GM1 ganglioside mimics the receptor function of GM1 for cholera toxin. Biochemistry 31:2422\u20132426","journal-title":"Biochemistry"},{"key":"9775_CR37","doi-asserted-by":"crossref","first-page":"e09545","DOI":"10.7554\/eLife.09545","volume":"4","author":"AM Wands","year":"2015","unstructured":"Wands AM, Fujita A, McCombs JE, Cervin J, Dedic B, Rodriguez AC, Nischan N, Bond MR et al (2015) Fucosylation and protein glycosylation create functional receptors for cholera toxin. Elife 4:e09545","journal-title":"Elife"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9775-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-016-9775-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9775-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-016-9775-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T20:51:26Z","timestamp":1692219086000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-016-9775-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,11]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["9775"],"URL":"https:\/\/doi.org\/10.1007\/s12035-016-9775-8","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,11]]}}}